Susquehanna International Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.4M Sell
595,500
-999,000
-63% -$69.6M ﹤0.01% 1526
2025
Q4
$106M Buy
1,594,500
+268,800
+20% +$17.4M 0.01% 849
2025
Q3
$89.2M Buy
1,325,700
+469,900
+55% +$37.2M 0.01% 965
2025
Q2
$74.7M Buy
855,800
+171,300
+25% +$13.4M 0.01% 915
2025
Q1
$46.7M Sell
684,500
-547,300
-44% -$44.7M 0.01% 1063
2024
Q4
$95.8M Buy
1,231,800
+530,400
+76% +$39.3M 0.01% 741
2024
Q3
$47M Buy
701,400
+363,600
+108% +$29.9M 0.01% 1143
2024
Q2
$38.3M Sell
337,800
-523,100
-61% -$66.1M 0.01% 1172
2024
Q1
$119M Sell
860,900
-475,500
-36% -$59.8M 0.02% 582
2023
Q4
$166M Buy
1,336,400
+355,100
+36% +$36.3M 0.03% 471
2023
Q3
$91.6M Buy
981,300
+280,600
+40% +$31.6M 0.02% 661
2023
Q2
$90M Buy
700,700
+367,900
+111% +$44.5M 0.02% 662
2023
Q1
$38.7M Sell
332,800
-1,115,200
-77% -$125M 0.01% 1120
2022
Q4
$164M Buy
1,448,000
+796,600
+122% +$87.5M 0.04% 387
2022
Q3
$52.5M Buy
651,400
+17,000
+3% +$1.44M 0.01% 774
2022
Q2
$47.3M Sell
634,400
-1,047,200
-62% -$95.6M 0.01% 885
2022
Q1
$215M Sell
1,681,600
-706,000
-30% -$77.2M 0.04% 375
2021
Q4
$321M Buy
2,387,600
+243,600
+11% +$35M 0.05% 331
2021
Q3
$293M Sell
2,144,000
-534,400
-20% -$67.4M 0.04% 381
2021
Q2
$286M Buy
2,678,400
+1,089,600
+69% +$105M 0.04% 373
2021
Q1
$143M Buy
1,588,800
+212,000
+15% +$19.9M 0.02% 583
2020
Q4
$127M Buy
1,376,800
+279,600
+25% +$25M 0.02% 567
2020
Q3
$113M Sell
1,097,200
-70,400
-6% -$7.36M 0.02% 525
2020
Q2
$118M Buy
1,167,600
+582,000
+99% +$52.1M 0.03% 449
2020
Q1
$39.4M Buy
585,600
+1,600
+0.3% +$99.6K 0.01% 772
2019
Q4
$31.9M Sell
584,000
-722,400
-55% -$34.3M 0.01% 1082
2019
Q3
$48.7M Buy
1,306,400
+673,200
+106% +$26.2M 0.02% 749
2019
Q2
$23.7M Sell
633,200
-287,200
-31% -$9.03M 0.01% 1159
2019
Q1
$27.4M Buy
920,400
+646,000
+235% +$22.7M 0.01% 977
2018
Q4
$8.22M Sell
274,400
-224,800
-45% -$7.13M ﹤0.01% 1784
2018
Q3
$17.9M Buy
499,200
+231,200
+86% +$7.17M 0.01% 1408
2018
Q2
$6.36M Sell
268,000
-36,000
-12% -$763K ﹤0.01% 2443
2018
Q1
$5.64M Buy
304,000
+239,600
+372% +$3.54M ﹤0.01% 2403
2017
Q4
$924K Sell
64,400
-466,400
-88% -$6.06M ﹤0.01% 5396
2017
Q3
$6.49M Buy
530,800
+398,400
+301% +$7.04M ﹤0.01% 2200
2017
Q2
$2.42M Sell
132,400
-250,400
-65% -$4.62M ﹤0.01% 3550
2017
Q1
$8.11M Buy
382,800
+87,600
+30% +$1.71M ﹤0.01% 1837
2016
Q4
$4.41M Sell
295,200
-70,400
-19% -$1.25M ﹤0.01% 2622
2016
Q3
$8.01M Sell
365,600
-30,000
-8% -$668K ﹤0.01% 1719
2016
Q2
$7.85M Buy
395,600
+248,000
+168% +$4.22M ﹤0.01% 1675
2016
Q1
$2.51M Buy
147,600
+71,600
+94% +$1.2M ﹤0.01% 3348
2015
Q4
$1.56M Sell
76,000
-684,400
-90% -$14.2M ﹤0.01% 4552
2015
Q3
$16.3M Buy
760,400
+598,800
+371% +$13.4M 0.01% 1399
2015
Q2
$3.23M Buy
161,600
+54,800
+51% +$962K ﹤0.01% 3711
2015
Q1
$1.66M Sell
106,800
-400
-0.4% -$6.04K ﹤0.01% 4680
2014
Q4
$1.48M Buy
107,200
+83,600
+354% +$1.02M ﹤0.01% 5073
2014
Q3
$236K Sell
23,600
-75,200
-76% -$769K ﹤0.01% 8396
2014
Q2
$980K Buy
98,800
+74,400
+305% +$659K ﹤0.01% 6093
2014
Q1
$252K Buy
+24,400
New +$252K ﹤0.01% 7868
2013
Q4
Sell
-125,200
Closed -$884K 9023
2013
Q3
$884K Buy
125,200
+70,800
+130% +$449K ﹤0.01% 5488
2013
Q2
$305K Buy
+54,400
New +$261K ﹤0.01% 6777

Other funds holding DXCM

Susquehanna International Group's DXCM Position: Q1 2026 in Review

Susquehanna International Group reduced its DexCom (DXCM) stake by 27% in Q1 2026, selling an estimated $9.6M and leaving 378,706 shares worth $23.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2012.

Susquehanna International Group first reported a position in DXCM in Q3 2013 and has held it in 49 quarters since. The position peaked at $136M in Q4 2021. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Susquehanna International Group held 378,706 shares of DexCom worth $23.8M as of Q1 2026.
  • Susquehanna International Group sold 137,900 DexCom shares in Q1 2026, an estimated $9.6M.
  • DexCom made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2012 holding.
  • Susquehanna International Group first reported a position in DexCom in Q3 2013 and has held it in 49 quarters since.
  • Susquehanna International Group's DexCom position peaked at $136M in Q4 2021.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.